Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 69Prostatic Neoplasms 47Breast Neoplasms 14Sarcoma 10Neoplasms 10Endometrial Neoplasms 9Vaginal Neoplasms 7Esophageal Neoplasms 6Uterine Neoplasms 4Radiation Injuries 4Lung Neoplasms 4Liver Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Adenocarcinoma 4Vulvar Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Hyperthermia 3Gliosarcoma 3Desmoplastic Small Round Cell Tumor 3Central Nervous System Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Brain Neoplasms 3Uveal Melanoma 2Rhabdomyosarcoma 2Retinoblastoma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2

Interventions

Radiosurgery 2Radiotherapy, Intensity-Modulated 1Radiation 1Proton Therapy 1Nivolumab 1Dihematoporphyrin Ether 1Cesium-131 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Recurrent Head and Neck Carcinoma × Brachytherapy × Clear all
NCT02467738 2025-09-19

Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
30 enrolled
Head & Neck

Recurrent Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡